Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Schenkein David P
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   168,823    

Indirect Shares

   417,826      
Direct Value   $5,035,310    

Indirect Value

   $13,780,226      
Total Shares   586,649      
Total Value   $18,815,536      


Agios Pharmaceuticals Inc $4,464,514 Foundation Medicine, Inc. $0 Bluebird Bio, Inc. $6,172 Denali Therapeutics Inc. $288,218 Regeneron Pharmaceuticals Inc $276,405 Agios Pharmaceuticals Inc $4,464,514 Foundation Medicine, Inc. $0 Bluebird Bio, Inc. $6,172 Denali Therapeutics Inc. $288,218 Regeneron Pharmaceuticals Inc $276,405
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    3    

     Stock price went up :
    0   
    3    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   3.0   
     Percentage Gain/Loss :
     0.0%
 35.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Agios Pharmaceuticals Inc AGIO Director 2024-02-27 122,854 2024-02-27 349,854    Premium*  
            Foundation Medicine, Inc. FMI Director 2016-06-16 23,326 2016-06-16 10,508    Premium*  
            Bluebird Bio, Inc. BLUE 2020-06-18 6,832 2014-12-19 0    Premium*  
            Denali Therapeutics Inc. DNLI Director 2023-06-01 15,529 2023-06-01 57,464    Premium*  
            Regeneron Pharmaceuticals Inc REGN Director 2024-01-02 282 2023-09-08 0    Premium*  
* Premium Members only  

Records found :    153         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-04-03 4 OE $0.30 $908 D/D 3,000 3,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-04-03 4 AS $58.62 $175,860 D/D (3,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-05-01 4 OE $0.30 $908 D/D 3,000 3,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-05-01 4 AS $50.06 $150,180 D/D (3,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-06-06 4 OE $0.30 $333 D/D 1,100 1,100 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-06-06 4 AS $50.02 $55,022 D/D (1,100) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-06-07 4 OE $0.30 $575 D/D 1,900 1,900 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-06-07 4 AS $50.02 $95,038 D/D (1,900) 0 0 -
BLUE Bluebird Bio, Inc. Director   –       •      –    2017-06-08 4 A $0.00 $0 D/D 1,000 3,176 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-07-03 4 OE $0.30 $908 D/D 3,000 3,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-07-03 4 AS $51.18 $153,540 D/D (3,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-08-01 4 OE $0.30 $908 D/D 3,000 3,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-08-01 4 AS $55.12 $165,360 D/D (3,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-08-02 4 AS $60.55 $1,453,200 D/D (24,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-08-02 4 OE $0.30 $7,260 D/D 24,000 24,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-09-01 4 OE $0.30 $1,815 D/D 6,000 6,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-09-01 4 AS $62.20 $373,200 D/D (6,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-09-07 4 GD $0.00 $0 I/I 500 271,772 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-09-18 4 AS $67.12 $2,349,200 D/D (35,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-09-18 4 OE $0.30 $10,588 D/D 35,000 35,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-10-02 4 OE $0.30 $1,815 D/D 6,000 6,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-10-02 4 AS $66.76 $400,560 D/D (6,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-10-04 4 OE $0.30 $24,200 D/D 80,000 80,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-10-04 4 AS $70.14 $5,611,200 D/D (80,000) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-11-01 4 OE $0.30 $1,815 D/D 6,000 6,000 0 -
  153  Records found
  1   2   3  4   5   6   7      
  Page 3 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us